These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22950702)

  • 1. Vildagliptin preserves the mass and function of pancreatic β cells via the developmental regulation and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes.
    Hamamoto S; Kanda Y; Shimoda M; Tatsumi F; Kohara K; Tawaramoto K; Hashiramoto M; Kaku K
    Diabetes Obes Metab; 2013 Feb; 15(2):153-63. PubMed ID: 22950702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DPP4 inhibitor vildagliptin preserves β-cell mass through amelioration of endoplasmic reticulum stress in C/EBPB transgenic mice.
    Shimizu S; Hosooka T; Matsuda T; Asahara S; Koyanagi-Kimura M; Kanno A; Bartolome A; Etoh H; Fuchita M; Teruyama K; Takahashi H; Inoue H; Mieda Y; Hashimoto N; Seino S; Kido Y
    J Mol Endocrinol; 2012 Oct; 49(2):125-35. PubMed ID: 22822047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipeptidyl peptidase-4 inhibitor, vildagliptin, inhibits pancreatic beta cell apoptosis in association with its effects suppressing endoplasmic reticulum stress in db/db mice.
    Wu YJ; Guo X; Li CJ; Li DQ; Zhang J; Yang Y; Kong Y; Guo H; Liu DM; Chen LM
    Metabolism; 2015 Feb; 64(2):226-35. PubMed ID: 25195070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vildagliptin ameliorates oxidative stress and pancreatic beta cell destruction in type 1 diabetic rats.
    Ávila Dde L; Araújo GR; Silva M; Miranda PH; Diniz MF; Pedrosa ML; Silva ME; de Lima WG; Costa DC
    Arch Med Res; 2013 Apr; 44(3):194-202. PubMed ID: 23523961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin on islet endocrine cells in non-obese type 2 diabetic Goto-Kakizaki rats.
    Inaba W; Mizukami H; Kamata K; Takahashi K; Tsuboi K; Yagihashi S
    Eur J Pharmacol; 2012 Sep; 691(1-3):297-306. PubMed ID: 22820107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the dipeptidyl peptidase-4 inhibitor vildagliptin on glucose tolerance and β-cell function and mass in insulin receptor substrate-2-knockout mice fed a high-fat diet.
    Sato K; Nakamura A; Shirakawa J; Muraoka T; Togashi Y; Shinoda K; Orime K; Kubota N; Kadowaki T; Terauchi Y
    Endocrinology; 2012 Mar; 153(3):1093-102. PubMed ID: 22315446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes.
    Shimoda M; Kanda Y; Hamamoto S; Tawaramoto K; Hashiramoto M; Matsuki M; Kaku K
    Diabetologia; 2011 May; 54(5):1098-108. PubMed ID: 21340625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combination therapy with vildagliptin and valsartan in a mouse model of type 2 diabetes.
    Miyagawa K; Kondo T; Goto R; Matsuyama R; Ono K; Kitano S; Kawasaki S; Igata M; Kawashima J; Matsumura T; Motoshima H; Araki E
    Cardiovasc Diabetol; 2013 Nov; 12():160. PubMed ID: 24188631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vildagliptin selectively ameliorates GLP-1, GLUT4, SREBP-1c mRNA levels and stimulates β-cell proliferation resulting in improved glucose homeostasis in rats with streptozotocin-induced diabetes.
    Akarte AS; Srinivasan BP; Gandhi S
    J Diabetes Complications; 2012; 26(4):266-74. PubMed ID: 22626875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between the islets blood flow, nitric oxide, insulin, and cytosolic calcium in rat pancreatic islets: effects of DPP-IV inhibitor vildagliptin.
    Akarte AS; Srinivasan BP; Gandhi S
    Eur J Pharm Sci; 2012 Apr; 45(5):546-51. PubMed ID: 22155545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vildagliptin Can Alleviate Endoplasmic Reticulum Stress in the Liver Induced by a High Fat Diet.
    Ma X; Du W; Shao S; Yu C; Zhou L; Jing F
    Biomed Res Int; 2018; 2018():5045182. PubMed ID: 29721506
    [No Abstract]   [Full Text] [Related]  

  • 12. Vildagliptin added to metformin on β-cell function after a euglycemic hyperinsulinemic and hyperglycemic clamp in type 2 diabetes patients.
    Derosa G; Ragonesi PD; Carbone A; Fogari E; Bianchi L; Bonaventura A; Romano D; Cicero AF; Maffioli P
    Diabetes Technol Ther; 2012 Jun; 14(6):475-84. PubMed ID: 22512264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DPP-4 inhibition improves glucose tolerance and increases insulin and GLP-1 responses to gastric glucose in association with normalized islet topography in mice with beta-cell-specific overexpression of human islet amyloid polypeptide.
    Ahrén B; Winzell MS; Wierup N; Sundler F; Burkey B; Hughes TE
    Regul Pept; 2007 Oct; 143(1-3):97-103. PubMed ID: 17482289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vildagliptin induces β-cell neogenesis and improves the lipid profile in a later phase of type 1 diabetes.
    de Amorim Miranda PH; Monteiro OM; Rossoni JV; Silva ME; de Lima WG; Costa DC
    Curr Pharm Biotechnol; 2015; 16(1):60-5. PubMed ID: 25395211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Pancreatic β Cell Mass by Cross-Interaction between CCAAT Enhancer Binding Protein β Induced by Endoplasmic Reticulum Stress and AMP-Activated Protein Kinase Activity.
    Matsuda T; Takahashi H; Mieda Y; Shimizu S; Kawamoto T; Matsuura Y; Takai T; Suzuki E; Kanno A; Koyanagi-Kimura M; Asahara S; Bartolome A; Yokoi N; Inoue H; Ogawa W; Seino S; Kido Y
    PLoS One; 2015; 10(6):e0130757. PubMed ID: 26091000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-cell expression of a dominant-negative HNF-1alpha compromises the ability of inhibition of dipeptidyl peptidase-4 to elicit a long-term augmentation of insulin secretion in mice.
    Ahrén B; Sörhede Winzell M; Burkey B; Hughes TE
    Eur J Pharmacol; 2005 Oct; 521(1-3):164-8. PubMed ID: 16171801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary restriction preserves the mass and function of pancreatic β cells via cell kinetic regulation and suppression of oxidative/ER stress in diabetic mice.
    Kanda Y; Hashiramoto M; Shimoda M; Hamamoto S; Tawaramoto K; Kimura T; Hirukawa H; Nakashima K; Kaku K
    J Nutr Biochem; 2015 Mar; 26(3):219-26. PubMed ID: 25488546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liraglutide, but not vildagliptin, restores normoglycaemia and insulin content in the animal model of type 2 diabetes, Psammomys obesus.
    Vedtofte L; Bodvarsdottir TB; Gotfredsen CF; Karlsen AE; Knudsen LB; Heller RS
    Regul Pept; 2010 Feb; 160(1-3):106-14. PubMed ID: 20005262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of Vildagliptin and Pioglitazone in Experimental Type 2 Diabetes in Male Rats.
    Refaat R; Sakr A; Salama M; El Sarha A
    Drug Dev Res; 2016 Sep; 77(6):300-9. PubMed ID: 27520857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cigarette smoke exposure impairs β-cell function through activation of oxidative stress and ceramide accumulation.
    Tong X; Chaudhry Z; Lee CC; Bone RN; Kanojia S; Maddatu J; Sohn P; Weaver SA; Robertson MA; Petrache I; Evans-Molina C; Kono T
    Mol Metab; 2020 Jul; 37():100975. PubMed ID: 32283079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.